Trial NCT02768558

View at ClinicalTrials.gov 
Org. Study IDs: RTOG 3505
Secondary IDs: CA209-333 RF 3505

Last trial update was posted on 2021-06-02

MeSH Interventions

Etoposide Nivolumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-Small Cell Lung Cancer

Stopping Reasons

Another treatment found efficacious

Limitations And Caveats

This study was terminated early due to the reporting of another study which changed this population's standard of care and rendered the control arm obsolete. Eight of the planned 550 analyzable participants were enrolled at the time of termination.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID